EP Patent

EP0354638A2 — Use of adenosine and its derivatives in diagnosis

Assigned to MedCo Research Inc · Expires 1990-02-14 · 36y expired

What this patent protects

The invention comprises the use, in the preparation of a diagnostic agent for parenteral administration to humans, of adenosine a functional adenosine receptor agonist including 1-­methyl-2-phenylethyl adenosine, 5-ethyl carboxamide adenosine, cyclopentyl adenosine and 2-chloro a…

USPTO Abstract

The invention comprises the use, in the preparation of a diagnostic agent for parenteral administration to humans, of adenosine a functional adenosine receptor agonist including 1-­methyl-2-phenylethyl adenosine, 5-ethyl carboxamide adenosine, cyclopentyl adenosine and 2-chloro adenosine; a metabolic precursor or by-product of adenosine including adenine and inosine; or a phosphorylated derivative of adenosine including adenosine monophosphate, adenosine diphosphate and adenosine triphosphate. The diagnostic agent is used in detecting the presence, or assessing the severity, of vascular disease.

Drugs covered by this patent

Patent Metadata

Patent number
EP0354638A2
Jurisdiction
EP
Classification
Expires
1990-02-14
Drug substance claim
No
Drug product claim
No
Assignee
MedCo Research Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.